Selective Inhibition of the Immunoproteasome With KZR-616 Blocks Multiple Cell Signaling Pathways, Plasma Cell Signatures and Myeloid Cell Associated Damage in the Nzb/w Lupus Nephritis Model
.
American College of Rheumatology Annual Meeting 2019 (ACR/ARP 2019).